TY - JOUR
T1 - Graphene oxide-Fe3O4 nanocomposite magnetic solid phase extraction followed by UHPLC-MS/MS for highly sensitive determination of eight psychoactive drugs in urine samples
AU - Lu, Qing
AU - Guo, Hao
AU - Zhang, Yuanyuan
AU - Tang, Xiaodong
AU - Lei, Weibin
AU - Qi, Ruijuan
AU - Chu, Junhao
AU - Li, Dezeng
AU - Zhao, Qingbiao
N1 - Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Graphene oxide–Fe3O4 (GO–Fe3O4) nanocomposite was synthesized by a facile chemical co-precipitation method. The GO–Fe3O4 was used as magnetic sorbent to extract the eight psychoactive drugs from urine samples. The analytes are morphine (MOR), 6-monoacetylmorphine (6-MAM), amphetamine (AMP), methamphetamine (MAMP), codeine, cocaine, dolantin and benzoylecgonine (BZE), which were determined by ultrahigh performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS). This method has high selectivity for the target analytes. The limit of detection (LOD) and limit of quantification (LOQ) were 0.02–0.2 μg L−1 and 0.05–0.5 μg L−1, respectively. The Mandel's fitting test revealed good linearity within all linear ranges. The linear ranges were calculated as 0.05–1000 μg L−1 for AMP, MAMP, cocaine and dolantin; 0.1–1000 μg L−1 for 6-MAM and codein; and 0.5–1000 μg L−1 for MOR and BZE. The recoveries ranged in 80.4–105.5%. The intra-day and inter-day RSDs are in the range of 2.7–13.1% and 3.9–13.7%, respectively. Magnetic solid phase extraction (MSPE) with GO–Fe3O4 provides a convenient, rapid and green sample pretreatment method for extracting the target psychoactive drugs from urine. This methodology can be used for simultaneous or individual detection of eight major psychoactive drugs with high sensitivity. This method has high potential in clinical and forensic areas for psychoactive drugs analysis.
AB - Graphene oxide–Fe3O4 (GO–Fe3O4) nanocomposite was synthesized by a facile chemical co-precipitation method. The GO–Fe3O4 was used as magnetic sorbent to extract the eight psychoactive drugs from urine samples. The analytes are morphine (MOR), 6-monoacetylmorphine (6-MAM), amphetamine (AMP), methamphetamine (MAMP), codeine, cocaine, dolantin and benzoylecgonine (BZE), which were determined by ultrahigh performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS). This method has high selectivity for the target analytes. The limit of detection (LOD) and limit of quantification (LOQ) were 0.02–0.2 μg L−1 and 0.05–0.5 μg L−1, respectively. The Mandel's fitting test revealed good linearity within all linear ranges. The linear ranges were calculated as 0.05–1000 μg L−1 for AMP, MAMP, cocaine and dolantin; 0.1–1000 μg L−1 for 6-MAM and codein; and 0.5–1000 μg L−1 for MOR and BZE. The recoveries ranged in 80.4–105.5%. The intra-day and inter-day RSDs are in the range of 2.7–13.1% and 3.9–13.7%, respectively. Magnetic solid phase extraction (MSPE) with GO–Fe3O4 provides a convenient, rapid and green sample pretreatment method for extracting the target psychoactive drugs from urine. This methodology can be used for simultaneous or individual detection of eight major psychoactive drugs with high sensitivity. This method has high potential in clinical and forensic areas for psychoactive drugs analysis.
KW - Graphene oxide
KW - Magnetic solid phase extraction
KW - Psychoactive drugs
KW - Tandem mass spectrometry
KW - Ultra-high performance liquid chromatography
UR - https://www.scopus.com/pages/publications/85070511763
U2 - 10.1016/j.talanta.2019.120212
DO - 10.1016/j.talanta.2019.120212
M3 - 文章
C2 - 31514841
AN - SCOPUS:85070511763
SN - 0039-9140
VL - 206
JO - Talanta
JF - Talanta
M1 - 120212
ER -